Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Staphylococcus aureus: A Microbial Mastermind

Riyaz Khan*

Staphylococcus aureus, a gram positive bacterium, has long been recognized as a significant human pathogen capable of causing a wide range of infections. This abstract provides an overview of the key aspects of Staphylococcus aureus, including its morphology, pathogenesis, antibiotic resistance, and clinical significance. Staphylococcus aureus is a spherical bacterium that forms clusters, characterized by its golden colored colonies on agar plates. It is part of the normal flora on human skin and mucous membranes, yet it can swiftly transition from a commensal organism to an opportunistic pathogen, causing infections in various body sites. This versatility can be attributed to the array of virulence factors produced by S. aureus, including adhesins, toxins and enzymes, which aid in colonization, evasion of the host immune system, and tissue damage. One of the most alarming characteristics of S. aureus is its ability to develop resistance to multiple antibiotics, presenting a considerable challenge in the management of infections caused by this organism. The emergence of Methicillin Resistant Staphylococcus aureus (MRSA) strains, resistant to beta lactam antibiotics, such as methicillin and penicillin, has further complicated treatment options, necessitating the use of alternative antimicrobial agents. Staphylococcus aureus infections can manifest as skin and soft tissue infections, bloodstream infections, pneumonia, bone and joint infections, and even more severe conditions, such as endocarditis and toxic shock syndrome. The clinical impact of S. aureus is further amplified by its ability to cause outbreaks in healthcare settings, highlighting the need for stringent infection control measures.

Published Date: 2024-12-24; Received Date: 2023-07-22